Clinical trials
Diabetes clinical trials
Below are recruiting diabetes clinical trials, each written for real people, not researchers. We’re tracking 2,208 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07222332RecruitingPhase 3
Baricitinib for new type 1 diabetes to save insulin-making cells
This trial tests if baricitinib, a pill that calms the immune system, can protect the remaining insulin-making cells in people newly diagnosed with type 1 diabetes. If it works, you might keep making some of your own insulin longer.
Aurora, ColoradoAges 1–35 - NCT06874907Recruiting
Predicting gestational diabetes with a glucose monitor in early pregnancy
This study tests whether wearing a continuous glucose monitor (a small sensor on your skin) in early pregnancy can help predict if you will develop gestational diabetes later. The goal is to catch it early so you and your baby get the best care possible.
El Palmar, MurciaAges 18 years+ - NCT06817265RecruitingPhase 3
TNTL for diabetic eye disease (non-proliferative)
This study tests if a drug called TNTL can help people with type 2 diabetes who have early-stage diabetic eye disease (non-proliferative diabetic retinopathy) without severe vision loss. It aims to see if the treatment is safe and effective in slowing or improving the condition.
Xuancheng, AnhuiAges 18–75 - NCT06773793Enrolling by invitation
Ultrasound test for nerve damage in diabetes
This trial uses a special ultrasound technique to see if it can detect nerve damage in people with diabetes. It may help doctors find diabetic peripheral neuropathy earlier and more accurately.
Nanjing, JiangsuAges 18–75 - NCT06619860RecruitingPhase 2
VX-993 for diabetic nerve pain
This trial tests a new medicine called VX-993 for people with diabetes who have had nerve pain in both feet or legs for at least a year. The goal is to see if it reduces pain and is safe.
Cullman, AlabamaAges 18–80 - NCT06412224RecruitingEarly Phase 1
Testing a new drug for diabetic eye disease after vitrectomy
This trial tests a new medicine, RRG001, given after vitrectomy surgery for severe diabetic eye disease. It aims to see if the drug is safe and helps prevent vision loss.
TianjinAges 20–80 - NCT06408207Recruiting
CGM Academy for Youth with Type 1 Diabetes
This study tests a program to help young people with type 1 diabetes learn to use continuous glucose monitors (CGMs) like Dexcom G6 and G7. It aims to improve diabetes management through education and support.
Los Angeles, CaliforniaAges 8–18 - NCT05838287RecruitingPhase 4
Pioglitazone for heart failure with preserved pumping in type 2 diabetes
This trial tests whether pioglitazone (a diabetes medicine) helps people who have type 2 diabetes and a specific type of heart failure where the heart pumps normally. It may improve heart failure symptoms and function in carefully selected patients.
San Antonio, TexasAges 30–70 - NCT05467150Recruiting
Probiotic supplement in pregnant people with gestational diabetes
This trial studies whether a probiotic supplement during late pregnancy and breastfeeding can improve health outcomes for babies born to people with gestational diabetes. You may be able to join if you plan to exclusively breastfeed and meet the nutrition, health, and lifestyle criteria.
Minneapolis, MinnesotaAges 21–45 - NCT04931537Recruiting
Testing early kidney marker tests for people with diabetes
This study looks for early warning signs in blood or other samples (using a special lab approach) to detect kidney problems sooner in people with diabetes. It may help patients and clinicians identify kidney risk earlier and follow changes over many years.
HangzhouAges 18–80 - NCT05390892RecruitingPhase 4
Preventing kidney and heart damage in type 2 diabetes
This study tests whether diabetes medicines can help prevent worsening heart and kidney problems in people with type 2 diabetes. You’ll be assigned by chance to one of these medicine types, and your other care will be adjusted for safety.
Huntsville, AlabamaAges 40–80 - NCT05916391RecruitingPhase 1
Gene therapy for diabetic macular swelling affecting vision
This early-stage (Phase 1) study tests a new gene therapy to improve vision for adults with diabetic macular edema. It mainly looks at whether the treatment can be safely given and may help your vision over time.
Tianjin, Tianjin,ChinaAges 18 years+ - NCT06802978Recruiting
Lipid test in diabetic and non-diabetic kidney patients
This study checks cholesterol and fat levels in the blood of people with chronic kidney disease, comparing those with and without diabetes. It aims to understand how kidney disease affects lipid profiles.
SohagAges 21 years+ - NCT03059069RecruitingPhase 4
Gliatamin for low mood in adults with type 2 diabetes
This trial tests whether gliatamin (choline alphoscerate) can improve depressive mood in people with type 2 diabetes. You may be eligible if your diabetes is fairly controlled and your depression symptoms are in a mild-to-moderate range.
SeoulAges 50 years+ - NCT07143773RecruitingPhase 4
SGLT2i safety in kidney transplant patients without diabetes
This study tests whether a medicine called SGLT2i (a type of pill for kidney health) is safe and helpful for kidney transplant recipients who do not have diabetes. It aims to see if it can improve how the new kidney works.
OdenseAges 18 years+ - NCT06196996Recruiting
Donor islet transplant for brittle type 1 diabetes
This study tests a one-time transplant of insulin-making cells from a donor to treat brittle type 1 diabetes—a condition where blood sugar swings wildly and dangerously low. The goal is to help people who still have severe low blood sugar episodes despite intensive insulin therapy.
Shanghai, Shanghai MunicipalityAges 6–65 - NCT06201611RecruitingPhase 2/Phase 3
Nebivolol for diabetic nerve damage study
This study tests whether the drug nebivolol (a type of beta-blocker) can help slow or reverse nerve damage caused by diabetes. It is for people with recent diabetes and confirmed neuropathy.
Bangalore, KarnatakaAges Up to 18 years - NCT06197412RecruitingPhase 4
Yunnan Baiyao for diabetic foot ulcers at different stages
This study tests whether Yunnan Baiyao, a traditional Chinese herbal medicine, helps heal diabetic foot ulcers at different stages. It looks at how well the medicine works and why, while providing standard wound care.
BeijingAges 18–80 - NCT06490484RecruitingPhase 2
A new capsule for diabetic nerve pain when pregabalin doesn't work
This trial tests an experimental drug (HSK16149) for people with long-term diabetic nerve pain that hasn't been helped enough by pregabalin. It aims to see if the new capsule can reduce pain more effectively.
Hangzhou, ZhejiangAges 18–75 - NCT06415643Recruiting
Lab-grown islet cells for diabetes after pancreas surgery
This trial tests whether lab-grown islet cells (pancreatic organoids) can help control blood sugar in people who develop diabetes after having most or all of their pancreas removed. If successful, this could reduce the need for insulin shots.
Hangzhou, ZhejiangAges 18–70 - NCT06318442Recruiting
Preventing steroid-induced diabetes with a GLP-1 drug
This study tests whether a GLP-1 medication (a type of drug that helps control blood sugar) can prevent diabetes caused by steroid treatments. It is for people who have prediabetes or mild diabetes and are about to receive a short course of steroids.
LondonAges 18 years+ - NCT05728476Recruiting
Compare eye surgery plus peeling versus anti-VEGF injections
This trial compares a minimally invasive eye procedure (vitrectomy with peeling) versus anti-VEGF injections to treat new diabetic macular edema in people who have not had treatment yet. It looks at which option improves vision and eye swelling for people with diabetes.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT07515079RecruitingPhase 3
Testing BAT5906 vs Lucentis for diabetic vision swelling
This study compares two injectable medicines (BAT5906 and Lucentis) to treat diabetic macular edema—swelling in the back of the eye that blurs vision. Both drugs block a protein that causes abnormal blood vessel leakage, and this trial will show which works better.
Beijing, Beijing MunicipalityAges 18–80 - NCT07717554Recruiting
Virtual yoga for diabetic stomach-pain relief
This study tests if virtual yoga classes can help people with diabetes and gastroparesis (slow stomach emptying) feel better. It looks at whether yoga can ease symptoms like nausea, bloating, and stomach pain.
Columbus, OhioAges 18–65
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetes?
- Yes. Clin2 currently lists 2,208 recruiting diabetes studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetes trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetes trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.